Site-specific protein cleavage is essential for many proteinproduction protocols and typically requires proteases. We report the development of a chemical protein-cleavage method that is achieved through the use of a sequence-specific nickel-assisted cleavage (SNAC)-tag. We demonstrate that the SNAC-tag can be inserted before both water-soluble and membrane proteins to achieve fusion protein cleavage under biocompatible conditions with efficiency comparable to that of enzymes, and that the method works even when enzymatic cleavages fail.
. Unfortunately, the enzymes added often need to be removed, which adds one more purification step. Enzymes can also be prohibitively expensive, especially when proteins are to be produced at large scales. Moreover, enzymatic cleavages often fail, and this is especially common for membrane proteins when the enzyme recognition site is proximal to the hydrophobic domain. Finally, detergents and denaturants, which are widely used to solubilize membrane proteins or proteins expressed in inclusion bodies, inactivate common proteolytic enzymes used to cleave tags 3 . One approach to circumvent enzymatic cleavage and its drawbacks is chemical cleavage. Cyanogen bromide has been used for chemical protein cleavages, but under harsh conditions with low sequence specificity (recognizing a single Met residue) 4 . Metal ions including Pd 2+ , Cu 2+ and Ni 2+ have also been explored to this end [5] [6] [7] [8] . The use of Pd 2+ and Cu 2+ has major obstacles, but Ni 2+ has shown more potential. It has been shown that Ni 2+ can cleave the sequence pattern -XSXHZ-before the Ser residue 7 . The best-optimized sequence was inserted in the mini-protein SPI-2 to show that cleavage can indeed progress 9, 10 . However, the reaction requires heating to 50 °C for approximately 20 h (refs. 9, 10 ), which makes this method impractically harsh for most proteins.
To find better methods for biocompatible chemical protein cleavage, we turned to substrate phage display 11 . We built a hexapeptide substrate phage library between an N-terminal AviTag 12 and M13 phage pIII protein (Fig. 1a) . We carried out four rounds of selection ( Supplementary Fig. 1 ) with increasingly stringent cleavage conditions (shorter incubation, lower temperature). We sequenced the final output phage libraries, and identified a consensus sequence pattern for cleavage using Ni 2+ ion (Fig. 1b) . This sequence pattern agrees with previous reports showing that Ser and His are very effective at positions P 1 ′ and P 3 ′ (ref. 13 ). We found a small but significant preference for His at P 2 ′ and for Thr at P 4 ′. We picked the two most enriched sequences and made the corresponding peptides to test the cleavage efficiency by highperformance liquid chromatography (HPLC). The most frequently observed sequence (-GSHHTDLP-) could achieve 90% cleavage at room temperature at pH 8.2 within 18 h (Fig. 1c) .
We found that Gly at the P 1 position is critical for high cleavage efficiency. A Gly-to-Ala replacement leads to a dramatically reduced cleavage rate ( Supplementary Fig. 2 ). This can be rationalized through the proposed cleavage mechanism ( Supplementary  Fig. 1 ), involving an Ni 2+ -assisted N-to-O acyl shift of the P 1 carbonyl to the P 1 ′ Ser side chain 14 . The resulting ester intermediate is then cleaved during the rate-limiting ester hydrolysis 7 , and hence is sensitive to steric effects that slow hydrolysis for residues other than Gly 15, 16 . We therefore introduced a Gly at position P1 of a previously reported cleavage sequence 7 to give -GSRHW-. This peptide performed slightly better than the best phage-selected sequence (Fig. 1c,d ). We further confirmed that His at the P 2 ′ position (-GSHHW-) indeed performs better than Arg (-GSRHW-) when embedded in a short peptide construct (Fig. 1d,e) . We then did a cleavage comparison without or with the critical Gly insertion on the mini-protein SPI-2 (ref. 9 ) (Supplementary Fig. 3 ). With the critical Gly insertion, the cleavage progressed to more than 90% yield (22 °C, 16 h). As expected, absence of the Gly gave only 15% cleavage yield under the same conditions. These data together designate the resulting sequence -GSHHW-as the sequence-specific nickel-assisted cleavage (SNAC)-tag, which was generated from the combined efforts of our phage selection, validation using synthetic peptides and previous reports 7 . We also examined the effect of buffers and exogenous nucleophiles on the rate of the cleavage reaction. We found that CHES and HEPES buffers performed the best ( Supplementary  Fig. 4 ), whereas the weak nucleophile acetone oxime could accelerate cleavage slightly without inducing nonspecific cleavages ( Supplementary Fig. 4) .
Encouraged by the activity of the SNAC-tag, in peptides and a small protein, we sought to examine its utility as a cleavable tag in a number of difficult cases where fusion-tag enzymatic cleavage is very inefficient. We first examined its utility in conjunction with a His-tag (6× His) fused to the N terminus of a water-soluble α-helical bundle protein, HB2225. Between the His-tag and HB2225, a cleavage site was included: either TEV (-ENLYFQS-; Fig. 2a ) or a SNACtag (-GSHHW-; Fig. 2b ). Cleavage by TEV protease under standard conditions was mostly incomplete (Fig. 2a) . However, cleavage of the SNAC-tag-containing construct yielded approximately 80% cleavage into the desired product (Fig. 2b) , with good reagent compatibility (Fig. 2c) . This result demonstrates that the SNAC-tag can indeed achieve biocompatible cleavage in full-sized globular proteins when enzymatic cleavage fails.
We next explored the utility of SNAC-tag for membrane-protein cleavage. In particular, we sought to cleave a construct consisting of a designed membrane protein 3hbtmV2 fused to T4 lysozyme via a TEV-cleavable linker. After screening a number of constructs, we found only a very low level of cleavage with TEV (less than 20%) (Fig. 2d) . By contrast, replacing the TEV substrate sequence with the SNAC-tag (-GSHHW-) at the same site resulted in more than 90% cleavage (Fig. 2e) . This demonstrates that SNAC-tag is perfectly compatible with cleavage of membrane proteins and detergent micelles. The SNAC-tag cleavage was further tested in two more water-soluble proteins and one more membrane protein; all cleavages achieved more than 80% completion at pH 8.2, 22 °C, 18 h ( Supplementary Fig. 7 ). In another T4L fusion membrane protein (T4L-PL5) in which thrombin cleavage was met with difficulty ( Supplementary Fig. 8 ), we inserted SNAC-tag to replace the thrombin cleavage sequence, and found that SNAC-tag could be effectively cleaved (Supplementary Fig. 8) .
We investigated the effect of different buffer and detergent conditions on the SNAC-tag cleavages (Fig. 2c,f,g ). Cleavage was fully compatible with common mild detergents, although the reaction was partially inhibited by sodium dodecyl sulfate (SDS) (Fig. 2g) . We found that strong denaturing conditions including 6 M guanidinium chloride or 8 M urea also were compatible with cleavage, though with decreased efficiency. Lower concentrations of up to 2 M guanidinium chloride or urea did not obviously affect cleavage efficiency (Supplementary Fig. 9 ). The SNAC-tag was most efficiently cleaved at pH 8.6, with a small decrease in yield at lower (8.2) and higher (9.0) pH. Removal of salt had little effect on T4L-3hbtmV2 cleavage, and only a modest effect for His-tag-HB2225 cleavage. We also found that HEPES and CHES buffers performed comparably, whereas the weakly Ni 2+ -chelating Tris buffer slowed the cleavage rate. The Ni 2+ concentration at 1 mM seemed to be necessary for efficient cleavage. Low levels of reducing agent (1 mM TCEP, 0.5 mM DTT) were compatible, and in fact cleavage of a Cyscontaining peptide showed negligible oxidation ( Supplementary   Fig. 10 ). For proteins that require low-temperature handling, cleavage at 4 °C was approximately four times slower than that at room temperature.
We studied the potential for cleaving SNAC-tag from proteins bound to Ni 2+ -nitrilotriacetic acid (NTA) resins, via a His-tag. One milligram of His-tag-T4L-GSHHW-3hbtmV2 was loaded onto a bed volume of 0.5 ml of Ni-NTA resin. After exchange into cleavage buffer, 1 mM NiCl 2 was added, and the reaction was incubated overnight at 22 °C ( Supplementary Fig. 11 ). On-resin cleavages proceeded nearly to completion, with efficiency similar to that observed in solution. No His-tag-containing protein was eluted off the beads during cleavage, nor did we observe protein cleavage while SNAC-tag-containing proteins were purified with Ni-NTA resins. Thus, SNAC-tag cleavage is compatible with Ni-NTA purifications and on-resin cleavages 10 . However, significant scale-up of protein loading for on-resin cleavage (50 mg protein per ml bed volume of Ni-NTA resin) resulted in visible protein precipitation as the cleavage proceeded, which suggests that loading is an important variable to consider for on-resin applications.
Knowing that Gly at the P 1 position plays a key role in the rate of hydrolysis, we generated a second targeted phage library (-X 1 X 2 X 3 GSX 4 HX 5 X 6 X 7 -) to further explore the influences of nearby residues on cleavage efficiency. We carried out four more rounds of selection and sequenced the final output library. We ranked each particular sequence observed in the output library (normalized to the control library: the same selection protocol in the absence of Ni 2+ ) shown in Supplementary Table 2 . Guided by this analysis, we then picked 11 distinct sequences from this selection and the top two sequences from the initial phage selection to replace the TEV substrate site in His-tag-HB2225 and in His-tag-T4L-3hbtmV2 for Ni 2+ cleavage. We confirmed that several of these SNAC-tag variants yielded more than 80% cleavage under our standard conditions (Fig. 2h) . For the watersoluble His-tag-HB2225, efficiency was slightly lower (Fig. 2i ). This result indicates that a number of diverse sequence combinations can be used to achieve high cleavage efficiency. All the high-ranking cleavage sequences are listed in Supplementary Table 2. To achieve high cleavage efficiency, Gly at P 1 , Ser at P 1 ′, and His P 3 ′ seem to be mandatory, whereas hydrophobic residues at P2′ are not favored. For the sequences listed in Fig. 2h ,i and Supplementary Table 2, the specific sequences seem to be important to achieve high cleavage efficiency, though we did not investigate further to find the minimal sequence for each individual sequence. Furthermore, cleavage requires correct geometry of the Ni 2+ complex ( Supplementary Fig. 1 ), and is likely to be achieved only in poorly structured protein regions AviTag Library M13 pIII We also systematically evaluated the effect of the surrounding residues by screening hundreds of peptides at five nearby positions (Supplementary Tables 3 and 4 ). Peptide sequences with faster cleavage than -GSHHW-were identified. However, they did not perform better when inserted in proteins ( Supplementary Fig. 12 ).
In summary, we have developed the SNAC-tag as a new chemical protein-cleavage strategy. The SNAC-tag can be inserted into both water-soluble and membrane proteins to achieve biocompatible protein cleavage in a sequence-specific manner with efficiency comparable to that of enzymes. The method is particularly attractive because it leaves only a small Gly residue at the C terminus of the released protein when it is used as a C-terminal tag. Additionally, this approach circumvents the demands of subsequent enzyme removal. Critically, we show cases where the SNAC-tag can succeed when enzymatic cleavage fails. We suggest using -GSHHW-as a general SNAC-tag, although -GSRHW-is also efficiently cleaved. Cleavage conditions are as follows: protein concentration approximately 1 mg ml −1 , 1 mM NiCl 2 , 0.1 M CHES buffer, 0.1 M acetone oxime, pH 8.6, incubation at room temperature, 0.1-0.5 M NaCl. For specific sequence requirements and additional cleavage details, consult the Methods. We expect the SNAC-tag to greatly reduce the cost and labor of recombinant-protein production at both laboratory and industrial scale and to find broad applications throughout medicine, basic biological research, and biotechnology.
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c le a v a g e Tables 1 and 2 . Full gels are shown in Supplementary Fig. 6 .
Reagents. All reagents were used without further treatment. Fmoc-protected amino acids were purchased from GL Biochem. 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU), trifluoroacetic acid (TFA), and hydroxybenzotriazole hydrate were purchased from Chem-Impex International. 4-Methylpiperidine was purchased from Acros Organics. Rink Amide-ChemMatrix resin (0.5 mmol g −1 loading) was purchased from Biotage. All other reagents, including Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), DL-dithiothreitol (DTT), N,N-dimethyldodecylamine N-oxide, N-dodecyl-N,N-dimethyl-3-ammonio-1 -propanesulfonate (C12 Betaine), and Triton X-100 were purchased from Sigma-Aldrich. Fos-choline-12 (DPC) and decyl β-dmaltopyranoside (DM) were purchased from Anatrace. SDS was purchased from Calbiochem. IPTG (isopropyl β-d-1-thiogalactopyranoside) was purchased from Genesee Scientific Corporation.
Protein gels and DNA gels. Precast NuPAGE 4-12% Bis-Tris polyacrylamide protein gels were purchased from Invitrogen. Protein gels were run at 200 V for 35 min in MES buffer. Gels were then washed nine times with warm water and stained with Coomassie blue for 4 h. They were then destained with tap water for 16 h before we imaged them on a Bio-Rad ChemiDoc MP imaging system. All protein bands were analyzed and quantified using Imagelab 5.2.1. Agarose DNA gels were made in-house using 1% UltraPure Agarose 1000 in TAE buffer with 0.01% EZ-Vision (Amresco). DNA gels were run at 150 V for 25 min and visualized under UV light.
Reverse-phase HPLC and mass spectrometry. Analytical reverse-phase HPLC analyses were performed on an Agilent 1100 series HPLC system using a Phenomenex Kinetex 2.6 μm C18, 50 × 2.1 mm column. Chromatographic separations were obtained using a linear gradient of 1-61% acetonitrile (with 0.08% TFA) in water (with 0.1% TFA) over 10 min, 1-41% acetonitrile (with 0.08% TFA) in water (with 0.1% TFA) over 20 min, or 1-41% acetonitrile (with 0.08% TFA) in water (with 0.1% TFA) over 40 min with the column at room temperature. Flow rates were controlled at 0.35 ml min . Peptide detection was based on UV absorption at 220 nm, and mass spectrometry data were obtained using a Shimadzu AXIMA Performance matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) spectrometer in a reflectron mode with α-cyano-4-hydroxycinnamic acid as the matrix.
Preparative HPLC. Products from solid-phase peptide synthesis were purified using a Phenomenex Jupiter 5.0 μm C4, 250 × 10.0 mm column. A shallow gradient of acetonitrile (with 0.08% TFA) versus water (with 0.1% TFA) was designed for each peptide on the basis of its elution characteristics. Flow rates were controlled at 5 ml min −1 . Fractions containing the desired pure peptide were identified by analytical HPLC and mass spectrometry, then combined and lyophilized.
Solid-phase peptide synthesis. All peptides were synthesized at 20 μmol scale using a Biotage Syro II parallel peptide synthesizer or at 0.1 mM scale using a Biotage Initiator + Alstra peptide synthesizer. Rink Amide-ChemMatrix resin (Biotage, 0.5 mmol g −1 loading) was used for the synthesis. A typical solid-phase peptide synthesis reaction cycle includes Fmoc deprotection, washing, coupling, and post-coupling washing steps. The deprotection was carried out for 5 min at room temperature with 20% 4-methylpiperidine in dimethylformamide (DMF). A standard double coupling was done for 8 min at room temperature or 5 min under microwave with 5 equivalents Fmoc-protected amino acids, 4.98 equivalents HCTU, and 10 equivalents DIEA (relative to the amino groups on resin) in DMF at a final concentration of 0.125 M amino acids.
Phage library construction. All phages were propagated in the Escherichia coli strain TG1 (Lucigen). E. coli CJ236 was purchased from Lucigen. The recombinantly expressed BirA enzyme used for biotinylating AviTag was a gift from the Wells laboratory at UCSF. Phagemid vector pCES1 was obtained from the Craik laboratory at UCSF. Pierce streptavidin-coated high-capacity plates were purchased from Thermo Fisher Scientific. The AviTag-displaying M13 phage libraries were constructed in phagemid vector pCES1. AviTag-TEV sequence was first fused to the N-terminal end of pIII protein in pCES1 vector using ApaL1 and Not1 restriction sites affording protein sequence as MGLNDIFEAQKIEWHEGGSENLYFQGG SAAAHHHHHHGAAEQKLISEEDLNG-. Single-strand M13 DNA was purified using the M13 DNA kit from Qiagen. For library construction, we followed a previously published protocol 19 . Phage libraries were constructed using an oligonucleotide encoding the reverse complement of protein sequence -IEWHEGGSXXXXXXGGSAAAHHH-using primer 5′-TGATGATGATGTGCGGCCGCACTACCACCMNNMNNMNNMNNMN NMNN GCTGCCGCCTTCATGCCATTCAAT-3′ for AviTag-XXXXXXlibrary, or using 5′-TGATGATGATGTGCGGCCGCACTACCACC MNNMNNMNNATGMNNACTACCMNNMNNMNNACCACCGCT GCCGCCTTCATGCCATTCAAT-3′ for AviTag-XXXGSXHX XX-library (codon M = A, C; N = A, C, T, G). Double-stranded DNA was generated according to published procedures 19, 20 and electroporated into TG1. Libraries with a size of 4 × 10 9 were generated and amplified for 15 h at 37 °C in 250 ml of 2xYT broth containing ampicillin (100 mg ml −1 ) and kanamycin (25 mg ml −1 final). For phage biotinylation, purified phages (4 × 10 12 colony-forming units (c.f.u.)) were resuspended in 0.5 ml of 10 mM Tris, pH 8.0, to exchange buffer (10 mM Tris, pH 8.0) three times using a 30 kDa molecular-weight cutoff tube. After buffer exchange, we added 40 μl of water and 80 μl of 2× biotinylation buffer (0.1 M Tris, 10 mM MgCl 2 , 2 mM biotin, pH 8.0) to wash the tube and get the solution to an Eppendorf tube. We added 20 μl of water and 20 μl of 2× biotinylation buffer to the centrifugation tube again to rinse it one more time. We then added approximately 6 μl of 0.1 M ATP and 2 μl of BirA enzyme (3 U μl −1 ) to the approximately 200 μl of phage solution, vortexed gently to mix well, and left it at 4 °C overnight for biotinylation. Anti-biotin western blotting was then conducted to confirm that phages were biotinylated.
Substrate phage-selection experiments. Four rounds of substrate selection were conducted (Supplementary Fig. 1 ). In round one, a streptavidin-coated ELISA plate was blocked with 2% BSA for 30 min and washed three times with phosphatebuffered saline containing 0.1% Tween 20 (PBST) buffer. We then coated the plate with approximately 10 9 phages (one well) by gently shaking the phages for 2 h. The unbound phages were washed out of the wells, well washed with PBST × 6, and batch washed with PBST (0.3 ml) for 3 × 20 min. Cleavage buffer containing 2 mM NiCl 2 , 0.1 M Tris, pH 9.0, was then added at 37 °C for 3 h. Cleaved phages were amplified overnight in 2xYT (30 ml) at 37 °C with shaking. We carried out the second, third and fourth rounds of selection by repeating the procedure above with the cleavage time decreased to 30 min and the cleavage temperature reduced from 37 °C to room temperature. Over different rounds of selection, the output phage titer was always around 3 × 10 8 c.f.u. We sequenced the final output phages by either picking colonies or doing deep sequencing.
We also ran a control selection along with the cleavage selections. In the control selection, all selection procedures were kept the same except in the elution step (cleavage step), which lacked added Ni 2+ in the Tris buffer. The purpose of performing control selection was to estimate sequence enrichment due to differences in growth rate or background-binding for individual displayed peptides.
Protein expression, purification, and cleavage. Initial HB2225 and 3hbtmV2 genes were introduced into a pET-28a vector (Novagen) via Gibson assembly; their sequences were confirmed (Genewiz San Francisco), and they were then transformed and expressed in One Shot BL21(DE3) chemically competent E. coli (Thermo Fisher Scientific). Different cleavage peptide sequences (Supplementary  Table 5 ) were then introduced into the pET-28a vector containing the HB2225 and 3hbtmV2 genes after Gibson assembly protocol (New England Biolabs).
Protein sequences are listed below:
His-tag-ENLYFQS-HB2225: MGSSHHHHHHSSGENLYFQSHMDYLRELLKL ELQAIKQYEKLRQTGDELVQAFQRLREIFDKGDDDSLEQVLEEIEELIQK HRQLASELPKLELQAIKQYREALEYVKLPVLAKILEDEEKHIEWLEEAA KQGDQWVQLFQRFREAIDKGDKDSLEQLLEELEQALQKIRELARLTRK ILEDEEKHIEWLETILG His-tag-GSHHW-HB2225: MGSSHHHHHHSSGGSHHWSHMDY LRELLKLELQAIKQYEKLRQTGDELVQAFQRLREIFDKGDDDSLEQVLE EIEELIQKHRQLASELPKLELQAIKQYREALEYVKLPVLAKILEDEEKHIEWLEE AAKQGDQWVQLFQRFREAIDKGDKDSLEQLLEELEQALQKIRELARLTRKILE DEEKHIEWLETILG His-tag-T4L-ENLYFQG-3hbtmV2: MGSSHH HHHHSSGLVPRGSHMGNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTK SPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKL KPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVN LAKSRWYNQTPNRAKRVITTFRTGTWDAYAAGGSGSTENLYFQSNSPDLE AWLLFIMLLTNALIFLAQKWVRETRDGDEAWKKIFLATFALNLLXXXXXX XXXXXXXXXXXXXXXXXXXTLAFNLLTILLGYKTIEGR (de novo-designed membrane protein; full sequence to be released in the future)
His-tag-T4L-GSHHW-3hbtmV2: MGSSHHHHHHSSGLVPRGS HMGNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKS ELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYD SLDAVRRAALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVN LAKSRWYNQTPNRAKRVITTFRTGTWDAYAAGGSGSTEGSHHWN SPDLEAWLLFIMLLTNALIFLAQKWVRETRDGDEAWKKIFLATFAL NLLXXXXXXXXXXXXXXXXXXXXXXXXXTLAFNLLTILLGYKTIEGR (de novo-designed membrane protein; full sequence to be released in the future)
For expressing HB2225 constructs, cells were grown in LB broth (25 mg ml −1 kanamycin), induced at 0.6-0.8 OD 600 with 1 mM IPTG and incubated for 4 h at 37 °C before cell collection. Cell pellets were resuspended in buffer containing 50 mM Tris, pH 8.0, 300 mM NaCl, 2% glycerol and lysed by sonication, and cell debris was subsequently removed by centrifugation (18,000 r.p.m. and 4 °C for 30 min). The soluble cell lysate was purified with Ni-NTA affinity chromatography.
For expressing 3hbtmV2 constructs, cells were grown in LB broth (25 mg ml −1 kanamycin), induced at 0.6-0.8 OD 600 with 0.4 mM IPTG and incubated overnight at 18 °C before cell collection. Cell pellets were resuspended in buffer containing 50 mM Tris, pH 8.0, 300 mM NaCl, 2% glycerol, 5 mM DPC and lysed by sonication, and cell debris was subsequently removed by centrifugation (18,000 r.p.m. and 4 °C for 30 min). The soluble cell lysate was purified with Ni-NTA affinity chromatography.
For cleavage of HB2225 constructs, proteins were first exchanged into buffer containing 0.1 M CHES, 0.1 M acetone oxime, 0.1 M NaCl at appropriate pH, and 1 mM NiCl 2 was then added, after which the solution was mixed well and left at room temperature (approximately 22 °C) for cleavage to proceed without shaking or stirring. Imidazole from Ni-NTA elution needs to be removed completely before cleavage. For cleavage of 3hbtmV2 constructs, the procedure is essentially the same as for HB2225, except appropriate detergents need to be added to the cleavage solutions. Cleavage efficiency was quantified using Imagelab 5.2.1 on the Bio-Rad ChemiDoc MP imaging system. A time-course cleavage of His-tag-T4L-GSHHW3hbtmV2 and His-tag-GSHHW-HB2225 is shown in Supplementary Fig. 13 .
TEV protease was purchased from Sigma-Aldrich. TEV cleavage was carried out under standard conditions: protein 1 mg ml −1 , 50 mM Tris, pH 8.0, 0.5 mM EDTA, 1 mM DTT, 0.25 M NaCl, 22 °C, 5 mM DPC, 16 h, TEV 0.04 mg ml −1 . We also tried TEV cleavage at 34 °C for His-tag-T4L-ENLYFQS-3hbtmV2 and His-tag-ENLYFQS-HB2225, and observed no obvious differences compared with 22 °C cleavage. We ran a positive control of TEV protease cleavage on a different protein that could be efficiently cleaved by TEV protease to show that TEV protease we obtained indeed was of good quality ( Supplementary Fig. 14) .
Thrombin was purchased from EMD Millipore. Cleavage conditions were as follows: 50 mM Tris, pH 8.4, 150 mM NaCl, 0.5 mM CaCl 2 , 5 mM DPC, 22 °C, 16 h. One thrombin unit is defined as the amount of enzyme required to cleave 1 mg of a test protein when incubated in standard digest buffer at 20 °C for 16 h.
Peptide cleavage screening.
As an alternative approach to explore the influence of nearby amino acids on cleavage efficiency, we made approximately 100 peptides (Supplementary Table 3 ), varying the amino acid identity individually around the cleavage site in the peptide WLX 1 X 2 SX 3 HX 4 X 5 . Peptide cleavage was carried out under cleavage conditions described above in Fig. 1 ; cleavage yields were quantified using the Agilent HPLC online system by integration of peak area. The sum of the extinction coefficient for the two product peaks was assumed to be the same as that for the initial peptide. We found that position X 5 had minimal impact on cleavage; position X 4 had a strong preference for Trp; position X 3 strongly preferred His; for position X 2 , His and Asn performed the best, followed by Lys and Arg; and position X 1 preferred Pro. We then further picked approximately 30 sequence combinations (Supplementary Table 4 ) and tested the cleavage efficiency. We found two sequence combinations (-PGSHHW-and -HNSHHW-) that indeed gave better cleavage efficiency ( Supplementary Fig. 12) . But when we then inserted these two sequences individually into the globular protein and membrane protein construct we had tested previously, unfortunately, they did not perform better ( Supplementary  Fig. 12 ). Thus, for searching best protein cleavage sequences, peptide models did not seem to be the best system. Protein-based selections such as phage display are probably more reliable, as we did here. Another thing to point out is that the amino-acid preference at the X 2 position did not fully hold up in a different peptide system (Supplementary Table 4 ), so we think Gly is still the best amino acid to use for best cleavage at the X 2 position.
A few tips for running cleavage reactions. For peptide cleavage tests, lyophilized peptides were dissolved in cleavage buffer (0.1 M CHES, 0.1 M NaCl, 0.1 M acetone oxime, pH 8.2 or otherwise noted in the text) at 0.2 mM concentration; 1 mM NiCl 2 was then added for the reaction to proceed without stirring or shaking.
We tested the compatibility of single unpaired cysteine with cleavage c onditions in a peptide sample (Supplementary Fig. 10 ) and observed no obvious Cys oxidation during the cleavage process. In cases where cysteine oxidation is observed, 1-2 mM TCEP could be added to keep cleavage under reducing conditions to minimize oxidation while keeping the cleavage rate essentially the same.
For the cleavage of short peptides, pH does make a big difference: cleavage rates increased about twofold from pH 8.2 to pH 8.6, as well as from pH 8.6 to pH 9.0 (Supplementary Fig. 15 ). However, this trend of rate increase did not hold for the two protein cleavage examples. We therefore recommend doing cleavage at pH 8.6, as it yielded slightly better performance in the two protein examples shown in Fig. 2 .
For some proteins, adding 1 mM NiCl 2 could cause protein precipitation. Under this situation, adding 0.5 M GuHCl to the protein solution before mixing protein with Ni 2+ could dramatically reduce protein precipitation without affecting cleavage efficiency ( Supplementary Fig. 9 ), as most of the proteins cannot be denatured with this diluted GuHCl concentration; we recommend using 0.5 M GuHCl when protein precipitation occurs. Alternatively, 1 mM TCEP could be added to the protein solution before the addition of NiCl 2 , as TCEP binds with Ni 2+ weakly and could minimize nonspecific metal-mediated protein-protein interactions, thus preventing protein precipitation. Other weak Ni 2+ ligands could potentially be explored to achieve the same result.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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